Analysis of German pharmaceutical market for ZCC arbitration

In a ZCC arbitration, CRA was retained to provide expert reports and testimony regarding the damages suffered by claimant due to the termination of a co-promotion agreement for the commercialization of a pharmaceutical in Germany.  As part of the damages assessment, CRA analyzed the German market for the product and the relative contribution to sales performance by each co-promotion partner.

Meet our team